Global Endotracheal Tube Market, by Product Type (Cuffed, Uncuffed, Armored/Reinforced, and Others), by Route (Orotracheal and Nasotracheal), by End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is expected to be valued at US$ 739.4 million in 2019, and is expected to exhibit a CAGR of 6.4% over the forecast period (2019-2027).

Increasing demand for advanced and efficient endotracheal tubes for to assist breathing in patient suffering from respiratory disorders is expected to provide immense growth opportunities for industry players operating in the global market over the forecast period. Moreover, key players in the market are focused on developing intubation systems to improve the endotracheal intubation procedure. For instance, in December 2016, Sanovas, Inc. launched LightSpeed Intubation System (LSI), a new and improved approach in endotracheal intubation. The system is offered by Intubation Science, Inc., a wholly owned subsidiary of Sanovas, Inc. The product is designed to improve accuracy and speed of endotracheal intubation procedure, and make airway management safer and faster.

Players operating in the market are focused on research for development of advanced and efficient product development, which is expected to drive the market growth over the forecast period. For instance, in August 2018, Teleflex initiated a U.S.-based clinical study for CleanSweep closed suction system. The CleanSweep system uses both sweeping balloon technology and conventional suction collection to remove secretion build-up inside the endotracheal tubes.

Browse 34 Market Data Tables and 30 Figures spread through 183 Pages and in-depth TOC on “Endotracheal Tube Market”- Global Forecast to 2027, by Product Type (Cuffed, Uncuffed, Armored/Reinforced, and Others), by Route (Orotracheal and Nasotracheal), by End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

To know the latest trends and insights prevalent in the global Endotracheal Tube market, click the link below:

https://www.coherentmarketinsights.com/market-insight/endotracheal-tube-market-2564

Key players in the market are focused on adoption of expansion strategies such as mergers and acquisitions, collaborations and partnerships, in order to expand their product portfolio and global presence in the endotracheal tube market. For instance, in August 2019, Novo Klinik-Service GmbH acquired Innocath GmbH, a Germany-based medical device manufacturing company. Under this acquisition, Novo Klinik-Service GmbH expanded its airway management product portfolio by adding Innocath’s products in its product portfolio.

Moreover, in January 2017, Bactiguard and Mediplast entered into a partnership for distribution of Bactiguard infection prevention products in European countries such as Belgium, the Netherlands, and Luxembourg.

Key Takeaways of the Global Endotracheal Tube Market:

  • The global endotracheal tube market is expected to exhibit a CAGR of 6.4% over the forecast period, owing to rising incidence of chronic respiratory diseases and increasing research and development activities. For instance, in November 2019, N8 Medical Inc. initiated the first in-human clinical trial for CeraShield Endotracheal Tube (ETT). The study aims to evaluate the safety of CeraShield ETT in intensive care unit patients who require longer hospital stay i.e., more than 48 hours.
  • Among product type, cuffed segment held a significant market share in 2018, owing to increasing prevalence of chronic respiratory diseases. For instance, according to an article titled 'The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016' by the National Center for Biotechnology Information, in 2016, Chronic obstructive pulmonary disease (COPD) and asthma were responsible for 75.6% and 20.0% of the chronic respiratory diseases respectively in India.
  • Among route, orotracheal segment held a significant market share in Orotracheal route is the most commonly used route for tracheal intubation, where an endotracheal tube is passed through the mouth, vocal apparatus and trachea. Intubation through the orotracheal route is easier, faster, less painful as compared to nasal intubation and convenient during laryngoscopic surgeries.
  • Companies operating in the global endotracheal tube market include Medtronic Plc, Teleflex Inc., ConvaTec Inc., Smiths Medical, Neurovision Medical Products, Intersurgical Inc., Royax, Novo Klinik-Service GmbH, Avanos Medical, Inc., Bactiguard, and N8 Medical LLC
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner